|
|
Research on the Effectiveness of Bepotastine Hesilate in the treatment of Primary Acquired Cold Urticaria |
TIAN Zhilan, ZHANG Liangqi, HOU Junrong, et al |
Cangxian Hospital, Hebei Cangzhou 061000, China |
|
|
Abstract Objective: To evaluate the efficacy and safety of bepotastine besilate in the treatment of primary acquired cold urticaria (PACU). Method: The selected PACU patients were randomly divided into experimental group and control group, were treated with benzenesulfonyl bepotastine besilate and placebo treatment, treatment for two weeks of pruritus and wheal response to cold stimulation test were observed, and the cold water or cold air to stimulate the emergence of clinical symptoms. Result: The itchy wheal reaction cold stimulation test and rewarming in 20 min patients with PACU in cold water or air after the wheal reaction and pruritus compared with the placebo group had significant difference (P<0.05). The incidence of adverse reactions was low. Conclusion: Mizolastine is safe and effective in the treatment of primary acquired cold urticaria.
|
|
|
|
|
[1] 赵辨.中国临床皮肤病学[M].南京:江苏科学技术出版社,2009:745~747. [2] 袁定贵,高进.玉屏风散对原发性获得性寒冷性荨麻疹临床疗效观察[J].世界中西医结合杂志,2014,9(9):962~964. [3] 窦海忠,杨伯艳,周桂林.中西医结合治疗原发性寒冷性荨麻疹[J].皮肤与性病,2012,34(5):278~279. [4] 陈文慧,刘乐,李伯埙.白芍总苷联合苯磺贝他斯汀治疗慢性荨麻疹疗效观察[J].中国中西医结合皮肤性病学杂志,2016,15(6):355~357. |
|
|
|